$DT

Dynatrace to acquire Arize in $915M AI observability deal

Dynatrace agreed to acquire AI observability firm Arize in a cash and stock deal valued at $915 million, according to Dynatrace. The companies expect closing later this quarter or early in Dynatrace’s third quarter, pending regulatory approval. The deal combines Arize’s AI model evaluation and hallucination detection with Dynatrace’s application, infrastructure, GPU and business-process observability.

Original reporting
Published Aug 14, 2026, 6:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 2:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dynatrace to acquire Arize in $915M AI observability deal — source image
Decision brief

The 30-second read

$DTBullishMed
01

Why it matters

The acquisition aims to unify AI evaluation and production observability, enabling end-to-end tracking from testing through deployment and ongoing monitoring, and feeding production signals back into AI development workflows.

02

Market read

A disclosed $915M M&A deal with a defined closing window creates immediate strategic and deal-execution trading interest, especially for AI observability positioning.

03

What to watch

The article omits financing details, purchase price allocation, and any regulatory risk assessment, which are key for deal-arb spreads and downside scenarios.

Relevance 8/10Novelty 8/10Timing: deal expected to close later this quarter or early in Dynatrace’s Q3, pending regulatory approval

Background

Dynatrace focuses on enterprise application and infrastructure monitoring, while Arize specializes in monitoring and evaluating AI models, including hallucination detection and output quality.

Company-level read

Ticker impact

$DTBullishMedium confidence
Context

Dynatrace agreed to acquire Arize in a $915M cash-and-stock deal, with closing expected later this quarter or early Q3 pending approvals.

Expected impact

Likely positive bias on deal spread and strategic premium, with volatility around regulatory/closing conditions.

Evidence & confidence

The article discloses a specific $915M transaction structure and timing window, which typically drives immediate sentiment and deal-arb positioning, but lacks details on financing, valuation mechanics, or regulatory outlook.

Market effects

Strengthens the AI observability and AIOps/AI-ops consolidation theme, potentially increasing competitive pressure on standalone AI evaluation tooling.

No specific regional demand or regulatory geography disclosed beyond generic regulatory approval.

AI operations and observability spend is global, but the article provides no region-specific expansion commitments.

Counterpoint

Strategic fit may not translate into near-term revenue acceleration; integration risk and customer churn could offset the premium implied by a $915M deal.

Key entities

  • Dynatrace

    Agreed to acquire Arize in a $915M cash-and-stock transaction to combine AI observability with its existing visibility platform.

  • Arize

    AI observability company focused on monitoring and evaluating AI models, applications, and agents, including hallucination and output quality measurement.

Related articles

$DTMed

Dynatrace Falls as Investors Weigh $915 Million Arize Deal

Dynatrace (DT) shares fell 3.3% as investors weighed its planned acquisition of Arize, announced Aug. 13. Dynatrace said the $915 million deal includes about $815 million in cash plus replacement equity awards. It expects about 200 bps ARR growth in fiscal 2027, but a 175 bps non-GAAP operating margin dilution, without changing Q2 guidance or its share repurchase program.

$DTMedAI 9/10

Dynatrace buys Arize AI for $915m: AI observability deal sealed

Dynatrace will acquire Arize AI in a cash-and-stock deal valued at $915 million, according to the companies. Dynatrace says the combination will support AI observability across the AI lifecycle, from evaluation to production monitoring of LLMs and agents. Dynatrace frames AI observability as a fast-growing market, projecting it could exceed $10 billion by 2030.

$DTMedAI 9/10

Dynatrace Boosts Its AI Observability Portfolio With Arize Acquisition

Dynatrace said it signed a definitive agreement to acquire Arize, developer of the Arize AX AI observability platform. The cash and stock deal is valued at $915 million, including about $815 million in cash. Dynatrace expects to close later this quarter or early in Q3, pending regulatory review. Arize founders will join Dynatrace.

$DTMed

DA Davidson reiterates Dynatrace stock Buy rating on Arize deal

DA Davidson reiterated a Buy rating and $65 price target on Dynatrace (DT) after it agreed to buy Arize for $915 million. The deal is expected to expand Dynatrace’s AI observability offering and add about 200 bps to ARR growth. The article also cites DT’s strong fiscal Q1 results and raised outlook, plus other firms lifting targets.